Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126300331 | 12630033 | 1 | I | 20160726 | 20160808 | 20160808 | EXP | US-TARO PHARMACEUTICALS USA.,INC-2016SUN00389 | TARO | 62.00 | YR | M | Y | 0.00000 | 20160808 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126300331 | 12630033 | 1 | PS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK | U | UNK | 18337 | ||||||||
| 126300331 | 12630033 | 2 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | 30 MG, 2 DOSES | U | 0 | 30 | MG | ||||||||
| 126300331 | 12630033 | 3 | C | CALCIUM CHLORIDE. | CALCIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 126300331 | 12630033 | 4 | C | D50W ampoule | 2 | U | 0 | ||||||||||||
| 126300331 | 12630033 | 5 | C | Insulin | INSULIN NOS | 1 | 10 UNITS, UNK | U | 0 | ||||||||||
| 126300331 | 12630033 | 6 | C | Acetylcysteine (NAC) | 2 | Intravenous (not otherwise specified) | 20 G, UNK | U | 0 | 20 | G | ||||||||
| 126300331 | 12630033 | 7 | C | Acetylcysteine (NAC) | 2 | Intravenous (not otherwise specified) | 10 G, UNK | U | 0 | 10 | G | ||||||||
| 126300331 | 12630033 | 8 | C | Pantoprazole drip | 2 | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126300331 | 12630033 | 1 | Product used for unknown indication |
| 126300331 | 12630033 | 2 | Product used for unknown indication |
| 126300331 | 12630033 | 3 | Product used for unknown indication |
| 126300331 | 12630033 | 4 | Product used for unknown indication |
| 126300331 | 12630033 | 5 | Product used for unknown indication |
| 126300331 | 12630033 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126300331 | 12630033 | DE |
| 126300331 | 12630033 | HO |
| 126300331 | 12630033 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126300331 | 12630033 | Acute hepatic failure | |
| 126300331 | 12630033 | Cardio-respiratory arrest | |
| 126300331 | 12630033 | Gastrointestinal haemorrhage | |
| 126300331 | 12630033 | Haematemesis | |
| 126300331 | 12630033 | Hyperkalaemia | |
| 126300331 | 12630033 | Multiple organ dysfunction syndrome | |
| 126300331 | 12630033 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |